When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BIOVF - Seelos on go to launch pivotal study of trehalose in Sanfilippo; shares up 7%
Swedish Orphan Biovit Ord
The FDA has signed off on Seelos Therapeutics' (SEEL+7.3%) IND for a Phase 2b/3 clinical trial evaluating SLS-005 (trehalose) in patients with mucopolysaccharidosis type III (Sanfilippo syndrome), an inherited disorder characterized by delayed speech and behavioral problems that is caused by the body's inability to break down large sugar molecules which accumulate in cells.
More news on: Seelos Therapeutics, Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Healthcare stocks news, Stocks on the move,